Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial*
Richard Bruce Warren, Andrew Blauvelt, Yves P. Poulin, Stefan Beeck, M. Kelly, Tianshuang Wu and 2 more
- Rank
- 15 of 908
- Percentile
- top 1.7%
- Where
- British Journal of Dermatology, 2020
- Citations
- 210
From the 2020 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.